Stay updated on Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.3.4 is now the latest update, replacing v3.3.3, and appears to be a minor site revision with no visible impact on core content or study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.3 appears in the page footer, and the HHS Vulnerability Disclosure link along with the Revision: v3.3.2 entry were removed from the footer. These changes affect only footer/policy elements and do not modify trial data or core page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2, indicating a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page removes the generic government funding/operating-status notice.SummaryDifference0.3%

- Check81 days agoChange DetectedVersion history shows multiple updates to core trial details (recruitment status, study status, and site/ contact information) across several versions. These changes reflect updates to current trial progress and site information.SummaryDifference0.0%

- Check110 days agoChange DetectedCore content updated with a government funding notice and a new version number (v3.2.0) replacing the old one (v3.1.0); reflects status and version changes rather than substantive feature additions.SummaryDifference7%

Stay in the know with updates to Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.